Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.75), $0.15 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.